Alexion Pharmaceuticals (ALXN)
Create an Alert
91.09
-1.30 -1.41%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
Alexion Pharmaceuticals Cash from Investing Quarterly:
-5.569M for March 31, 2013Alexion Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -5.569M |
| Dec. 31, 2012 | -7.59M |
| Sept. 30, 2012 | -6.239M |
| June 30, 2012 | -4.559M |
| March 31, 2012 | -609.20M |
| Dec. 31, 2011 | 0.661M |
| Sept. 30, 2011 | 7.592M |
| June 30, 2011 | 31.00M |
| March 31, 2011 | -72.96M |
| Dec. 31, 2010 | -9.978M |
| Sept. 30, 2010 | -55.42M |
| June 30, 2010 | -21.64M |
| March 31, 2010 | -2.276M |
| Dec. 31, 2009 | -27.71M |
| Sept. 30, 2009 | -7.514M |
| June 30, 2009 | -27.23M |
| March 31, 2009 | -18.97M |
| Dec. 31, 2008 | -17.61M |
| Sept. 30, 2008 | -10.17M |
| June 30, 2008 | -8.711M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
ALXN Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Biogen Idec | 155.94M |
| Alkermes | -111.83M |
| Anika Therapeutics | 0.0998M |
ALXN Cash from Investing Quarterly Rankings
| Overall |
70th percentile 5026 of 16782 |
| Sector |
53rd percentile 655 of 1410 in Healthcare |
| Industry |
41st percentile 265 of 454 in Biotechnology |
ALXN Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -609.20M | Mar 2012 |
| Maximum | 31.00M | Jun 2011 |
| Average | -43.71M |
